Sales Must Be Good, AMRN Starting Plans For 4th Supplier. // posted.
Amarin Announces Approval of Supplemental New Drug Application for BASF as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier
"This sNDA approval of BASF as a supplier of Vascepa follows the recent sNDA approval to add Chemport, Inc. as a Vascepa API supplier and brings the number of approved Vascepa API suppliers to three. The BASF approval represents an additional step toward the goal of expanding our global supply chain to support expected Vascepa demand, diversify our supply base, and ensure cost-efficient supply. In addition, Amarin has plans for the submission of a fourth planned supplier in 2013.